AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profileg
AstraZenecaUK

@ASTRAZENECAUK

Pushing the boundaries of science for patients, creating value for the UK. Not responsible for external links. Community guidelines: https://t.co/8Z69SsViVS

ID:2900752222

linkhttp://www.astrazeneca.co.uk calendar_today01-12-2014 15:49:36

2,7K Tweets

5,3K Followers

362 Following

AstraZeneca(@AstraZeneca) 's Twitter Profile Photo

Today we revealed a bold ambition to deliver $80bn in total revenue by 2030 ($45bn in 2023). We are set to launch 20 new medicines by 2030 as we bring patients next generation therapies. We will also halve emissions across our value chain by 2030.

account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

Today, we are at the ARNS 💙 Conference 2024, where AstraZeneca is an exhibitor. We aim to empower nurses with the latest clinical research and knowledge to drive positive change in patient outcomes.

Today, we are at the @ARNS_UK Conference 2024, where AstraZeneca is an exhibitor. We aim to empower #respiratory nurses with the latest clinical research and knowledge to drive positive change in patient outcomes.
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

Last week saw where Tom Keith-Roach, President, AstraZeneca UK, joined the respiratory community in calling for government action. Read his reflection and future hope for asthma care in the UK here: bit.ly/3yt9VIa

Last week saw #WorldAsthmaDay2024 where Tom Keith-Roach, President, AstraZeneca UK, joined the respiratory community in calling for government action. Read his reflection and future hope for asthma care in the UK here: bit.ly/3yt9VIa #AsthmaCare
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

Today we welcomed Roland Sinker, CEO of Cambridge University Hospitals NHS to our strategic R&D centre, The DISC, to discuss the Ecosystem in the UK and the importance of working in partnership across the sector to drive innovation development, adoption and spread.🔬

Today we welcomed Roland Sinker, CEO of @CUH_NHS to our strategic R&D centre, The DISC, to discuss the #Innovation Ecosystem in the UK and the importance of working in partnership across the #LifeSciences sector to drive innovation development, adoption and spread.🔬
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

We were delighted to see this important debate in the Scottish Parliament for . With around 17% of Scots living with and approximately 4% may have , we're dedicated to ensuring timely diagnosis and treatment access for all with asthma.

We were delighted to see this important debate in the Scottish Parliament for #WorldAsthmaDay2024. With around 17% of Scots living with #asthma and approximately 4% may have #severeasthma, we're dedicated to ensuring timely diagnosis and treatment access for all with asthma.
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

Today, we stand with clinicians, patients and system partners in the respiratory community, at the All Party Parliamentary Group (APPG) for Respiratory Health at UK Parliament, to call for a zero-tolerance approach to deaths.

Today, we stand with clinicians, patients and system partners in the respiratory community, at the All Party Parliamentary Group (APPG) for Respiratory Health at @UKParliament, to call for a zero-tolerance approach to #asthma deaths. #WorldAsthmaDay2024 #NRADat10 #Asthmacare
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

10 years after the National Review of Asthma Deaths, outcomes in the UK are still amongst the worst in Europe.

On , we join leaders from the respiratory community to tackle this burden and reduce avoidable asthma deaths.

10 years after the National Review of Asthma Deaths, #asthma outcomes in the UK are still amongst the worst in Europe. On #WorldAsthmaDay2024, we join leaders from the respiratory community to tackle this burden and reduce avoidable asthma deaths. #NRADat10 #Asthmacare
account_circle
AstraZenecaUK(@ASTRAZENECAUK) 's Twitter Profile Photo

Can reform of NHS incentives help release cancer service capacity? Our Head of Oncology UK, David Brocklehurst, argues that a new approach can inject much needed capacity and deliver better patient outcomes. Read more in this sponsored article in @HSJ: shorturl.at/hjFY6

account_circle